Medicine
Liomny 5 mcg tablet
Liomny 5 mcg tablet is a prescription medicine containing Liothyronine for oral use, marketed by Sigmapharm Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store between 15°C and 30°C (59°F and 86°F).
Key facts
- Active ingredient (INN)
- Liothyronine
- Brand
- Liomny
- Strength
- 5 mcg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 30 tablets and 2 more
- Marketing authorisation holder
- Sigmapharm Laboratories
- Manufacturer
- Sigmapharm Laboratories
- Origin register
- US FDA, United States
- Storage
- Store between 15°C and 30°C (59°F and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 21 November 2025
- Identifiers
- RxCUI 903456, 903697, 903703 +3DailyMed set ID 0dcec611-2b7a-4cf3-80c3-7389be2f0a94NDC 42794-131Application ANDA200295
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 42794-131-02 | Sigmapharm Laboratories | 21 November 2025 |
| 1000 tablet in 1 bottle | 42794-131-06 | Sigmapharm Laboratories | 21 November 2025 |
| 30 tablet in 1 bottle | 42794-131-08 | Sigmapharm Laboratories | 21 November 2025 |
| 60 tablet in 1 bottle | 42794-131-10 | Sigmapharm Laboratories | 21 November 2025 |
| 90 tablet in 1 bottle | 42794-131-12 | Sigmapharm Laboratories | 21 November 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 8 May 1956 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Liothyronine 5 mcg tablet.
Other strengths and forms of Liothyronine
Clinical summary
Liothyronine is a l-triiodothyronine indicated for hypothyroidism, among other approved uses. It is available as tablets and injection for oral and intravenous use. MedsAcross supplies Liothyronine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about LiothyronineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Liothyronine Sodium prescribing information (Mylan Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Liomny 5 mcg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.